Literature DB >> 15822561

Tylosin-responsive chronic diarrhea in dogs.

Elias Westermarck1, Teresa Skrzypczak, Jaana Harmoinen, Jõrg M Steiner, Craig G Ruaux, David A Williams, Erkki Eerola, Pernilla Sundbäck, Minna Rinkinen.   

Abstract

Fourteen dogs had shown chronic or intermittent diarrhea for more than 1 year. Diarrhea had been successfully treated with tylosin for at least 6 months but recurred when treatment was withdrawn on at least 2 occasions. Tylosin-responsive diarrhea (TRD) affects typically middle-aged, large-breed dogs and clinical signs indicate that TRD affects both the small and large intestine. Treatment with tylosin eliminated diarrhea in all dogs within 3 days and in most dogs within 24 hours. Tylosin administration controlled diarrhea in all dogs, but after it was discontinued, diarrhea reappeared in 12 (85.7%) of 14 dogs within 30 days. Prednisone given for 3 days did not completely resolve diarrhea. Probiotic Lactobacillus rhamnosus GG did not prevent the relapse of diarrhea in any of 9 dogs so treated. The etiology of TRD, a likely form of antibiotic-responsive diarrhea (ARD) is unclear. The following reasons for chronic diarrhea were excluded or found to be unlikely: parasites, exocrine pancreatic insufficiency, inflammatory bowel disease, small intestinal bacterial overgrowth, enteropathogenic bacteria (Salmonella spp., Campylobacter spp., Yersinia spp., or Lawsoni intracellularis), and Clostridium perfringens enterotoxin and Clostridium difficile A toxin. A possible etiologic factor is a specific enteropathogenic organism that is a common resident in the canine gastrointestinal tract and is sensitive to tylosin but difficult to eradicate. Additional studies are required to identify the specific cause of TRD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15822561     DOI: 10.1892/0891-6640(2005)19<177:tcdid>2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  21 in total

1.  Chronic Enteropathy in Dogs-Epidemiologic Aspects and Clinical Characteristics of Dogs Presenting at Two Swedish Animal Hospitals.

Authors:  Johanna Holmberg; Lena Pelander; Ingrid Ljungvall; Caroline Harlos; Thomas Spillmann; Jens Häggström
Journal:  Animals (Basel)       Date:  2022-06-09       Impact factor: 3.231

2.  Evaluation of Fecal Microbiota Transfer as Treatment for Postweaning Diarrhea in Research-Colony Puppies.

Authors:  Erin N Burton; Erin O'Connor; Aaron C Ericsson; Craig L Franklin
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

3.  Effects of the macrolide drug tylosin on chronic diarrhea in rhesus macaques (Macaca mulatta).

Authors:  Rebecca S Blackwood; Ross P Tarara; Kari L Christe; Abigail Spinner; Nicholas W Lerche
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

4.  Effect of tylosin on dogs with suspected tylosin-responsive diarrhea: a placebo-controlled, randomized, double-blinded, prospective clinical trial.

Authors:  Susanne Kilpinen; Thomas Spillmann; Pernilla Syrjä; Teresa Skrzypczak; Maria Louhelainen; Elias Westermarck
Journal:  Acta Vet Scand       Date:  2011-04-14       Impact factor: 1.695

5.  Evaluation of a therapy for Idiopathic Chronic Enterocolitis in rhesus macaques (Macaca mulatta) and linked microbial community correlates.

Authors:  Joshua M Taylor; Erik L Clarke; Kate Baker; Abigail Lauder; Dorothy Kim; Aubrey Bailey; Gary D Wu; Ronald G Collman; Lara Doyle-Meyers; Kasi Russell-Lodrigue; James Blanchard; Frederic D Bushman; Rudolf Bohm
Journal:  PeerJ       Date:  2018-04-11       Impact factor: 2.984

6.  Genome-wide association studies of inflammatory bowel disease in German shepherd dogs.

Authors:  Atiyeh Peiravan; Francesca Bertolini; Max F Rothschild; Kenneth W Simpson; Albert E Jergens; Karin Allenspach; Dirk Werling
Journal:  PLoS One       Date:  2018-07-20       Impact factor: 3.240

7.  Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment.

Authors:  Katja Kalenyak; Romy M Heilmann; Chris H A van de Lest; Jos F Brouwers; Iwan A Burgener
Journal:  PLoS One       Date:  2019-04-16       Impact factor: 3.240

8.  Evaluation of a structured individualised protocol as a potential cost-effective diagnostic and therapeutic approach to chronic diarrhoea in the dog.

Authors:  Christine E Bryan; Jeb C Cade; Andrew J Mackin; Alyssa M Sullivant
Journal:  Vet Med Sci       Date:  2019-02-11

9.  The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing.

Authors:  Jan S Suchodolski; Scot E Dowd; Elias Westermarck; Jörg M Steiner; Randy D Wolcott; Thomas Spillmann; Jaana A Harmoinen
Journal:  BMC Microbiol       Date:  2009-10-02       Impact factor: 3.605

10.  Efficacy of two low-dose oral tylosin regimens in controlling the relapse of diarrhea in dogs with tylosin-responsive diarrhea: a prospective, single-blinded, two-arm parallel, clinical field trial.

Authors:  Susanne Kilpinen; Thomas Spillmann; Elias Westermarck
Journal:  Acta Vet Scand       Date:  2014-08-06       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.